CCRP THERAPEUTICS
CCRP Therapeutics is a biopharmaceutical spin-off of Charitรฉ's Center for Cardiovascular Research (CCR). The company's focus is the discovery of renin/ prorenin receptor blockers (RERBs) for multiple oncological indications (colorectal cancer, hepatocellular carcinoma, pancreatic cancer and sarcoma) as well as for the treatment of end-organ damage caused by diabetes and hypertension.
CCRP THERAPEUTICS
Industry:
Biotechnology Therapeutics
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.ccrp-therapeutics.com
Status:
Active
Contact:
+ 49 (0)30 450 569 233
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content TYPO3
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Current Employees Featured
Official Site Inspections
http://www.ccrp-therapeutics.com
- Host name: w0e.rzone.de
- IP address: 81.169.145.78
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529

More informations about "CCRP Therapeutics"
Our Team - CCRP therapeutics
Dmitry joined CCRP Therapeutics as a consultant in 2020 and became CEO in 2023. He holds an MA in Economics and Management from Humboldt University of Berlin, along with โฆSee details»
CCRP Therapeutics - Crunchbase Company Profile & Funding
CCRP Therapeutics is a biopharmaceutical spin-off of Charité's Center for Cardiovascular Research (CCR). The company's focus is the discovery of renin/ prorenin receptor blockers โฆSee details»
CCRP therapeutics: Drug discovery
First-in-class small molecule drug discovery of renin/ prorenin receptor blockers (RERBs) In cooperation with the contract research organizations Evotec AG and Experimental โฆSee details»
CCRP Therapeutics - VentureRadar
858 Therapeutics USA Privately Held 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in โฆSee details»
CCRP Therapeutics - Crunchbase
CCRP Therapeutics GmbH is a biopharmaceutical spin-off of Charité's Center for Cardiovascular Research (CCR). New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the new โฆSee details»
CCRP Therapeutics GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CCRP Therapeutics GmbH of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»
Ccrp Therapeutics GmbH - Drug pipelines, Patents, Clinical trials
Explore Ccrp Therapeutics GmbH with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
CCRP Therapeutics GmbH - Life-Sciences-Europe.com
ITM to Supply Radioisotope Ac-225 to Ariceum Therapeutics; ... BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl โ the โฆSee details»
Malignancies (CCRP) - Drug Targets, Indications, Patents - Synapse
Malignancies(CCRP), Initially developed by Ccrp Therapeutics GmbH, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication: Neoplasms, Active โฆSee details»
CCRP Therapeutics (CCRP Therapeutics GmbH) - Startbase
Recent mentions of CCRP Therapeutics in podcasts & videos: Jobs at CCRP Therapeutics: Other Startups nearby. CATHAGO. Startup 2021 Berlin. CATHAGO. Platform for construction โฆSee details»
CCRP Therapeutics - Overview, News & Similar companies
CCRP Therapeutics is a biopharmaceutical spin-off of Charité's Center for Cardiovascular Research (CCR). The company's focus is the discovery of renin/ prorenin receptor blockers โฆSee details»
CCRP therapeutics: Scientific Background
Therefore, the aim of CCRP Therapeutics is to develop a small molecule drug class called renin/ prorenin receptor blockers (RERBs) as first-in-class therapy for cancers and for end-organ โฆSee details»
CCRP Therapeutics GmbH im Startup-Atlas
CCRP Therapeutics ist ein führendes biopharmazeutisches Unternehmen, das sich auf die Entwicklung von innovativen Renin/Prorenin-Rezeptorblockern (RERBs) spezialisiert hat. โฆSee details»
Contact - CCRP therapeutics
You may contact us on info(at)ccrp-therapeutics.com. or Heiko Funke-Kaiser via hfk(at)ccrpt.de. (Alternatively you can also use this form, please fill out the fields marked with * to contact you โฆSee details»
CCRP Therapeutics - Contacts, Employees, Board Members
CCRP Therapeutics GmbH is a biopharmaceutical spin-off of Charité's Center for Cardiovascular Research (CCR). New. Resources. Advanced Search. Start Free Trial . ... Experience the new โฆSee details»
Introducing Cannovation Clinical Research Partners, LLC (CCRP, โฆ
[Atlanta, GA, April 19, 2024] โ Cannovation Clinical Research Partners, a pioneering Cannabis-Based Clinical Research Organization for Drug and Product Development, is proudly โฆSee details»
Cannovation Clinical Research Partners Announces New Divisions โฆ
Feb 4, 2025 We are pleased to announce the new changes within our organization as of January 1, 2025. Starting with our new Chief Scientific Officer Dr. James Linden. Cannovation Clinical โฆSee details»
CCRP Therapeutics (CCRP Therapeutics GmbH) - Startbase
Offene Jobs bei CCRP Therapeutics: Weitere Startups in der Nähe von CCRP Therapeutics. CATHAGO. Startup 2021 Berlin. CATHAGO. Plattform für Bauunternehmen, die es โฆSee details»
Clinical Research Practices, Professionals, and Participants in the ...
Apr 29, 2025 Signature Series speakers took on more of the clinical research enterpriseโs โbig pictureโ topics at ACRP 2025 on Saturday, focusing on the implications for clinical trials teams โฆSee details»
Our Partners - CCRP therapeutics
Collaborations and partnerships are an essential part of CCRP Therapeutics' business strategy. We welcome requests from potential partners who are interested in working with us.See details»